[Clinical evaluation of the therapeutic activity of the  -pyridyl-carbinol ester of clofibric acid].
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D004562:Electrocardiography; D004952:Esters / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D000432:Methanol / Q000627:therapeutic use; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D010991:Plethysmography; D011725:Pyridines / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014665:Vasodilator Agents / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D004952:Esters; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D011725:Pyridines; D014280:Triglycerides; D014665:Vasodilator Agents; D014527:Uric Acid; D002784:Cholesterol; D002994:Clofibrate; D000432:Methanol
Valutazione clinica dell'attività terapeutica dell'estere  -piridil-carbinolico dell'ac. clofibrico.